Bailey R R, Lynn K L, Peddie B A, Walker R J, Swainson C P
N Z Med J. 1986 Jun 25;99(804):459-61.
A randomised trial was undertaken to compare the efficacy of netilmicin and ceftriaxone for the treatment of severe or complicated urinary tract infections. Forty-seven patients completed the study. Twenty-three of 24 patients treated with netilmicin and 21 of 23 treated with ceftriaxone were cured. One patient treated with netilmicin had a mild, reversible disturbance of renal function. Six patients developed diarrhoea after ceftriaxone treatment.
进行了一项随机试验,以比较奈替米星和头孢曲松治疗严重或复杂性尿路感染的疗效。47名患者完成了该研究。接受奈替米星治疗的24名患者中有23名治愈,接受头孢曲松治疗的23名患者中有21名治愈。一名接受奈替米星治疗的患者出现轻度、可逆的肾功能障碍。6名患者在头孢曲松治疗后出现腹泻。